• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Permasteelisa

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Investors

21 Invest and Holding Bau, a company owned by the management of Permasteelisa, have reached an agreement for the joint management of a 29.9% stake in Permasteelisa, a company listed on the Milan Stock Exchange. These stakes will be syndicated and represent the relative majority of Permasteelisa share capital. Following this agreement, 21 Invest will acquire approximately 15% of Permasteelisa in return for an investment ofEUR81.8m (with 21 Invest providing EUR54.5m) from a company owned by management, which currently holds 29.9% of the company’s equity. Both parties have agreed to enter into a shareholders’ agreement that will cover certain areas such as corporate governance, lock-ups and exit strategies. On the basis of a valuation of 100% of Permasteelisa equal to EUR520m, 21 Invest will pay Holding Bau EUR18.8 per share, of which EUR17 is to be paid at closing and EUR1.8 as deferred consideration. Completion of the transaction is subject to the approval of the relevant antitrust authorities. Debt facilities of EUR27.3m were provided by Banca Popolare di Milano.

Company

Permasteelisa is the global leader in the engineering, manufacturing and installation of curtain walls and cladding for buildings. Among the buildings clad by the group are: the Sydney Opera House, the European Parliament in Brussels and Strasbourg, Deutsche Bank and European Central bank headquarters in Frankfurt, Channel 4, Lloyds, HSBC, France Television headquarters in Paris, ABN AMRO headquarters in Amsterdam, Capital Tower and the Stock Exchange in Singapore, the Guggenheim Museum in Bilbao and the Times Square tower in New York. The company operates through a network of more than 60 companies located in more than 25 countries across four continents. Permasteelisa generated revenues of EUR791m in 2001 and EUR860m of backlog by 31 December 2001. The company is headquartered in the US and has holdings in Singapore, Sydney, the Netherlands and Treviso in Italy. Commenting on 21 Invest’s strategy, Andrea C. Bonomi, chairman of 21 Invest, said: ‘Permasteelisa makes an excellent platform for a buy-and-build strategy in a sector of the market where attractive opportunities are becoming available at this point of the economic cycle. Although the main initial driver for the transaction is a buy-and-build, we will consider a public-to-private at a later stage if both stock market and industrial market conditions warrant it.

People

Andrea C. Bonomi, John Mowinckel, Salvatore Catapano and Roberto Maestroni coordinated the deal for 21 Invest. The Holding Bau team was led by Giancarlo Iovino, Enzo Pavan and Lucio Mafessanti.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Southern Europe
  • Industrials

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013